1.1 Patient Assessment, Medical History & Communication

1.1 Patient Assessment, Medical History & Communication

Patient Identification Protocols

In the high-stakes environment of a nuclear medicine department, ensuring that the correct radiopharmaceutical is administered to the correct patient is the absolute most critical first step of any procedure. The Joint Commission's National Patient Safety Goals strictly require the use of at least two independent patient identifiers before any clinical intervention.

This protocol is not merely a suggestion; it is a rigid standard designed to prevent catastrophic medical errors. Acceptable identifiers include the patient's full, legal name; their date of birth; or a unique hospital-assigned medical record number (MRN). Importantly, these identifiers must be cross-referenced with the patient's wristband, the physician's order, and the radiopharmaceutical dose ticket.

Technologists must employ active identification techniques. Instead of asking a closed-ended question such as, "Are you John Doe?", the technologist must ask, "Can you please state your full name and date of birth?" This prevents patients who are hard of hearing, distracted, or cognitively impaired from reflexively saying "yes" to the wrong name. Location-based identifiers, such as a bed number or waiting room seat, are explicitly forbidden as primary identifiers because patients frequently move or are moved.

Comprehensive Medical History Gathering

Gathering a medical history in nuclear medicine goes far beyond a simple checklist; it is an investigative process that directly impacts the diagnostic quality of the study. The technologist must act as a detective to uncover variables that might alter the biodistribution of the radiotracer.

1. Chief Complaint and Current Symptoms: Why is the patient here? Understanding the exact nature of their pain or dysfunction allows the technologist to tailor the imaging protocol, such as adding additional views of a specific symptomatic area during a bone scan.
2. Past Surgical History: Surgical alterations of anatomy drastically change the appearance of nuclear medicine scans. For example, knowing a patient has had a cholecystectomy is vital before a hepatobiliary (HIDA) scan; otherwise, the absence of the gallbladder might be falsely interpreted as acute cholecystitis. Similarly, a previous nephrectomy will result in only one functioning kidney appearing on a renal scan.
3. Current and Recent Medications: A vast array of pharmaceuticals can interfere with radiotracers. For instance, patients undergoing a radioactive iodine uptake test (RAIU) must discontinue thyroid hormones (Synthroid) and antithyroid medications (methimazole) for weeks prior. Patients scheduled for a myocardial perfusion imaging study using pharmacological stress agents (like dipyridamole or regadenoson) must withhold caffeine for 12-24 hours, as caffeine acts as a direct receptor antagonist and will invalidate the test.
4. Prior Imaging Studies: Reviewing recent CT, MRI, or previous nuclear medicine scans provides essential baseline data. It helps in correlating functional abnormalities seen on the nuclear scan with structural abnormalities identified on anatomic imaging.

Managing Pregnancy and the 10-Day Rule

Ionizing radiation poses a significant teratogenic and oncogenic risk to a developing fetus, particularly during the first trimester (organogenesis). Therefore, confirming pregnancy status is a non-negotiable requirement for female patients of childbearing potential (generally considered ages 12 to 55, though institutional policies may vary).

The technologist must explicitly ask and document the date of the patient's last menstrual period (LMP). If there is any uncertainty, a serum or urine human chorionic gonadotropin (hCG) test should be ordered and the results verified before administering any radioactive material.

Historically, the 10-Day Rule was widely utilized in radiology and nuclear medicine. This rule recommended that non-urgent procedures involving radiation exposure to the pelvic region in women of reproductive age should only be scheduled during the first 10 days of their menstrual cycle (day 1 being the onset of menstruation). The rationale is that during this 10-day window, the probability of the patient being pregnant is exceedingly low. While many modern departments have shifted toward a 28-day rule or rely entirely on objective pregnancy testing due to the availability of rapid assays, the 10-day rule remains a foundational concept in radiation protection and is frequently tested on the ARRT exam.

For breastfeeding mothers, special precautions are necessary. Many radiopharmaceuticals are excreted in breast milk. Depending on the physical half-life and biological excretion rate of the isotope (e.g., Gallium-67, Iodine-131), the mother may need to suspend breastfeeding temporarily or completely. The technologist must consult the specific package insert and physicist recommendations to advise the patient on pumping and discarding breast milk.

Advanced Communication Strategies

Communication in nuclear medicine is a two-way street that requires empathy, clarity, and adaptability. Patients often arrive highly anxious, associating the word "nuclear" or "radiation" with danger, or fearing the potential diagnosis the scan might reveal.

• Therapeutic Communication and Active Listening: The technologist must maintain eye contact, use a reassuring tone, and validate the patient's feelings. Phrases like "I understand this can be stressful, but I will be with you the entire time" help build trust.
• Setting Expectations: A critical component of compliance is ensuring the patient knows exactly what to expect. The technologist must explain the two-part nature of many scans (e.g., injection, waiting period, imaging). They must explain that the camera will come very close to their body but will not touch them, and emphasize the absolute necessity of remaining perfectly still to avoid motion artifacts that could render the scan non-diagnostic.
• Overcoming Barriers: When communicating with pediatric patients, technologists should lower themselves to the child's eye level, use age-appropriate terms (e.g., calling the camera a "spaceship"), and involve parents in the process. For non-English speaking patients, the use of a certified medical interpreter is legally and ethically required; relying on family members for complex medical translation is strongly discouraged.

Vital Signs and Patient Monitoring

While nuclear medicine is generally less invasive than surgery, adverse reactions and medical emergencies can and do occur, particularly during pharmacological stress testing or interventional procedures. Establishing a baseline set of vital signs is essential.

• Blood Pressure (BP): Measured using a sphygmomanometer. A normal resting adult BP is <120/80 mmHg. Hypertension or hypotension can dictate whether certain adjunct medications (like captopril) can be safely administered.
• Heart Rate and Rhythm: Normal is 60-100 beats per minute. Tachycardia or bradycardia must be documented. During cardiac stress tests, continuous 12-lead ECG monitoring is mandatory.
• Respiratory Rate: Normal is 12-20 breaths per minute.
• Oxygen Saturation (SpO2): Measured via pulse oximetry; normal is 95-100%. Patients with COPD or those receiving sedation require close monitoring.

The Process of Informed Consent

Informed consent is not merely a signature on a piece of paper; it is a comprehensive educational process. While routine diagnostic nuclear medicine scans generally require only implied or general consent, therapeutic procedures (e.g., I-131 for thyroid cancer, Y-90 microspheres) or those involving significant risk require formal written informed consent.

The consent process must clearly outline:

1. The exact nature and purpose of the proposed procedure.
2. The known risks, potential complications, and expected benefits.
3. Viable alternatives to the procedure.
4. The risks of refusing the procedure.

Consent must be obtained by a physician, though the technologist plays a crucial role in verifying that the consent form is signed, dated, and placed in the patient's chart before the procedure begins. The patient must be competent and not under the influence of sedatives when giving consent.